Literature DB >> 2788195

Bacteriologic epidemiology of Hemophilus influenzae type b strains causing invasive infections in Finland.

A K Takala1, L van Alphen, J M Musser, L Geelen, R K Selander, J Eskola, P H Mäkelä.   

Abstract

Consecutive Hemophilus influenzae type b (Hib) isolates (333 total) from children with invasive disease in Finland in 1985-1986 were analyzed. All belonged to the common genetic clusters described in the USA and Europe. However, detailed typing demonstrated some characteristics unique to Hib strains in Finland. Of the isolates, 86% belonged to one of four distinct patterns according to the combination of outer membrane protein subtype, biotype, and lipopolysaccharide serotype: 1-I-1 (25%), 1-II-9 (8%), and 1c-I-1 (18%). Pattern 1-II-9 has not been previously reported; it was most commonly found in the most densely populated area of Finland and among children cared for outside the home. Multilocus enzyme electrophoresis revealed that 87% of isolates with the pattern 1c-I-1 belonged to the electrophoretic type 21.8, which is seldom recovered from patients with invasive Hib disease in other countries.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788195     DOI: 10.1093/infdis/160.2.237

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Molecular characteristics of Haemophilus influenzae causing invasive disease during the period of vaccination in Switzerland: analysis of strains isolated between 1986 and 1993.

Authors:  K Muhlemann; M Balz; S Aebi; K Schopfer
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

2.  Neonatal Haemophilus influenzae infections.

Authors:  A K Takala; E Pekkanen; J Eskola
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

3.  Antibodies to Haemophilus influenzae type b outer membrane proteins in children with epiglottitis or meningitis and in healthy controls.

Authors:  P D Johnson; S J MacInnes; G L Gilbert
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.